Lipocine Inc
Research Lipocine Inc (LPCN) on Bullrun: market cap USD 17.73M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLPCN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 17.73M
- Financial periodQ2 2026
- RevenueUSD 190.10K
- Net income-USD 2.62M
- Free cash flow-USD 3.03M
- Gross margin-973.9%
Valuation Snapshot
latest market cap is USD 17.73M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.98M | -USD 9.63M | -USD 9.76M | n/a | -1.69 | USD 5.21M | n/a | USD 14.48M |
| FY2024 | USD 11.20M | USD 10.00K | -USD 1.31M | n/a | -0.35 | USD 6.21M | n/a | USD 21.00M |
| FY2023 | -USD 2.85M | -USD 16.35M | -USD 11.88M | n/a | -3.14 | USD 4.77M | n/a | USD 20.37M |
| FY2022 | USD 500.00K | -USD 10.76M | -USD 12.10M | n/a | -2.15 | USD 3.15M | USD 2.32M | USD 35.63M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 17.73M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 49.45M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 26.10M | 488.0 | n/a | n/a |
| 2023 | 2023-12-29 | USD 14.83M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 35.25M | 8.6 | n/a | n/a |
| 2021 | 2021-12-31 | USD 87.51M | n/a | n/a | n/a |
About Lipocine Inc
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. It also develops LPCN 1154 (BRLIZIO), an oral neuro-steroid in a Phase 3 pivotal trial for postpartum depression;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lipocine Inc's market cap?
Lipocine Inc's market capitalization is USD 17.73M.
What does Lipocine Inc do?
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate.